Focal Therapy for Prostate Cancer Using HIFU
Recruiting
N/A
Interventional Study
Male Erectile Disorder
Prostate Cancer
Therapy-related Toxicity
Urinary Incontinence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 90
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 354 (estimated)
- Sponsor
- University College, London · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
RATIONALE: Prospective trials using hemi-ablation with high intensity focused ultrasound (HIFU) (Sonablate 500) have demonstrated feasibility, safety, and encouraging functional outcomes and early cancer control with 90% of men achieving trifecta status (no erectile dysfunction, leak-free pad-free continence, cancer control). However, these trials have involved small numbers of patients with men s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
1. Histologically proven prostate cancer on trans-rectal or transperineal template prostate biopsies.
2. Prostate biopsy (either TRUS or MRI Targeted or Template):
* TRUS biopsy: up to burden bilateral disease with maximum 3mm one biopsy on non-dominant side is allowable.
* MRI targeted and/o…
Contacts
No contact information available.